Clostridium difficile ribotype 027 is most prevalent among inpatients admitted from long-term care facilities

Journal of Hospital Infection

Volumn 88, Issue 4, 2014, Pages 218-221

  Archbald Pannone, L R ^a   Boone, J H ^b   Carman, R J ^b   Lyerly, D M ^b   Guerrant, R L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b TECHLAB INC   (United States)

Author keywords

Clostridium difficile infection; Long term care residents; Nosocomial diarrhoea; Strain BI NAP1 027

Indexed keywords

PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; CLOSTRIDIUM DIFFICILE RIBOTYPE 027; ENTERITIS; HOSPITAL PATIENT; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MORTALITY; PEPTOCLOSTRIDIUM DIFFICILE; POPULATION; PREVALENCE; AGED; CLASSIFICATION; CROSS INFECTION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; RIBOTYPING; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; FLUOROQUINOLONES; HUMANS; INPATIENTS; LONG-TERM CARE; MIDDLE AGED; RIBOTYPING;

EID: 84920026575     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2014.06.016     Document Type: Article

References (9)

1. Simor A.E., Bradley S.F., Strausbaugh L.J., Crossley K., Nicolle L.E. Clostridium difficile in long-term-care facilities for the elderly. Infect Control Hosp Epidemiol 2002, 23:696-703. SHEA Long-Term-Care Committee.
2. Archbald-Pannone L., Sevilleja J., Guerrant R. Diarrhea, Clostridium difficile, and intestinal inflammation in residents of a long-term care facility. JAm Med Dir Assoc 2010, 11:263-267.
3. Rupnik M., Wilcox M.H., Gerding D.N. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 2009, 7:526-536.
4. Redelings M.D., Sorvillo F., Mascola L. Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. Emerg Infect Dis 2007, 13:1417-1419.
5. Kim J.H., Toy D., Muder R. Clostridium difficile infection in a long-term care facility: hospital-associated illness compared with long-term care-associated illness. Infect Control Hosp Epidemiol 2011, 32:656-660.
6. Inns T., Gorton R., Berrington A., et al. Effect of ribotype on all-cause mortality following Clostridium difficile infection. JHosp Infect 2013, 84:235-241.
7. Boone J., Archbald-Pannone L., Wickman K., et al. Ribotype 027 Clostridium difficile infections with measurable stool toxin have increased lactoferrin and are associated with a higher mortality. Eur J Clin Microbiol Infect Dis 2014, 33:1045-1051.
8. Walk S.T., Micic D., Jain R., et al. Clostridium difficile ribotype does not predict severe infection. Clin Infect Dis 2012, 55:1661-1668.
9. Pawlowski S.W., Archbald-Pannone L., Carman R.J., et al. Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C.difficile. JHosp Infect 2009, 73:185-187.